Impulse control disorders in Parkinson's disease: Crossroads between neurology, psychiatry and neuroscience

Behavioural Neurology

Volumn 27, Issue 4, 2013, Pages 547-557

  Bugalho, Paulo ^a,b   Oliveira Maia, Albino J ^c,d,e  

^a HOSPITAL EGAS MONIZ   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c Centro Hospitalar de Lisboa Ocidental   (Portugal)

^d INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^e CHAMPALIMAUD CENTRE FOR THE UNKNOWN   (Portugal)

Author keywords

dopamine; frontostriatal circuits; impulse control disorders; non motor symptoms; Parkinson's disease

Indexed keywords

COGNITIVE DEFECT; COMORBIDITY; DYSKINESIA; EXECUTIVE FUNCTION; FRONTAL LOBE; HALLUCINATION; HUMAN; IMPULSE CONTROL DISORDER; NEUROLOGY; NEUROSCIENCE; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOSIS; REVIEW;

DOPAMINE; FRONTOSTRIATAL CIRCUITS; IMPULSE CONTROL DISORDERS; NON-MOTOR SYMPTOMS; PARKINSON'S DISEASE;

ANIMALS; CEREBRAL CORTEX; COGNITION DISORDERS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; HUMANS; IMPULSE CONTROL DISORDERS; MENTAL DISORDERS; NEURAL PATHWAYS; PARKINSON DISEASE;

EID: 84883488521     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.1155/2013/826742     Document Type: Review

References (105)

1. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med. 1998;339(16):1130-1143. (Pubitemid 28465762)
2. Ziemssen T, Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2007;13(6): 323-332. (Pubitemid 47212791)
3. Soh SE, Morris ME, McGinley JL. Determinants of healthrelated quality of life in Parkinson's disease: A systematic review. Parkinsonism Relat Disord. 2011;17(1):1-9.
4. Chaudhuri KR, Naidu Y. Early Parkinson's disease and nonmotor issues. J Neurol. 2008;255 Suppl 5:33-38.
5. Bugalho P, da Silva JA, Cargaleiro I, Serra M, Neto B. Psychiatric symptoms screening in the early stages of Parkinson's disease. J Neurol. 2012;259(1):124-131.
6. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589-595.
7. Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne EJ, Burns A. Behavioural disorders, disability and quality of life in Parkinson's disease. Age Ageing. 2011;40(5):614-621.
8. Leroi I, Harbishettar V, Andrews M, McDonald K, Byrne EJ, Burns A. Carer burden in apathy and impulse control disorders in Parkinson's disease. Int J Geriatr Psychiatry. 2012;27(2):160-166.
9. Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron. 2009;61(4):502-510.
10. Singh A, Kandimala G, Dewey RB, Jr, O'Suilleabhain P. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists. J Clin Neurosci. 2007;14(12):1178-1181. (Pubitemid 350102789)
11. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, et al. Factors associated with dopaminergic drugrelated pathological gambling in Parkinson disease. Arch Neurol. 2007;64(2):212-216.
12. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord. 2007;22(12):1757-1763. (Pubitemid 47597599)
13. Poletti M, Bonuccelli U. Impulse control disorders in Parkinson' disease: the role of personality and cognitive status. J Neurol. 2012.
14. Delaney M, Leroi I, Simpson J, Overton PG. Impulse control disorders in Parkinson's disease: Apsychosocial perspective. J Clin Psychol Med Settings. 2012;19(3):338-346.
15. Weintraub D, Siderowf AD, Potenza MN, Goveas J,Morales KH, Duda JE, et al. Association of dopamine agonist usewith impulse control disorders in Parkinson disease. Arch Neurol. 2006;63(7):969-973. (Pubitemid 44036299)
16. Imamura A, Geda YE, Slowinski J,Wszolek ZK, Brown LA, Uitti RJ. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol. 2008;15(4):350-354. (Pubitemid 351422391)
17. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology. 2006;67(7):1258-1261. (Pubitemid 44563839)
18. Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc. 2009;84(4):310-316.
19. Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, et al. Long-term follow-up of impulse control disorders in Parkinson's disease.MovDisord. 2008;23(1):75-80. (Pubitemid 351281221)
20. Dang D, Cunnington D, Swieca J. The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome. Clin Neuropharmacol. 2011;34(2):66-70.
21. Martinkova J, Trejbalova L, Sasikova M, Benetin J, Valkovic P. Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clin Neuropharmacol. 2011;34(5):179-181.
22. Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, et al. Impulsivity and compulsivity in drug-naive patients with Parkinson's disease. Mov Disord. 2011;26(3):464-468.
23. Broen M, Duits A, Visser-Vandewalle V, Temel Y, Winogrodzka A. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord. 2011;17(6):413-417.
24. Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci. 2009;16(9):1148-1152.
25. Ceravolo R, Frosini D, Rossi C, Bonuccelli U. Spectrum of addictions in Parkinson's disease: From dopamine dysregulation syndrome to impulse control disorders. J Neurol. 2010;257(Suppl 2):S276-S283.
26. Owen AM, Sahakian BJ, Hodges JR, Summers BA, Polkey CE, Robbins TW. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology. 1995;9(1):126-140.
27. Menzies L,ChamberlainSR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525-549. (Pubitemid 351173336)
28. Bugalho P, Correa B, Guimaraes J, Xavier M. Set-shifting and behavioral dysfunction in primary focal dystonia. Mov Disord. 2008;23(2):200-206. (Pubitemid 351311548)
29. Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC. Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2003;15(3):371-374. (Pubitemid 36999383)
30. Harbishettar V, Pal PK, Janardhan Reddy YC, Thennarasu K. Is there a relationship between Parkinson's disease and obsessive-compulsive disorder? Parkinsonism Relat Disord. 2005;11(2):85-88. (Pubitemid 40279147)
31. Alegret M, Junque C, Valldeoriola F, Vendrell P, Marti MJ, Tolosa E. Obsessive-compulsive symptoms in Parkinson's disease. JNeurolNeurosurg Psychiatry. 2001;70(3):394-396. (Pubitemid 32250900)
32. Siri C, Cilia R, De Gaspari D, Villa F, Goldwurm S,Marco C, et al. Psychiatric symptoms in Parkinson's disease assessed with the SCL-90R self-reported questionnaire. Neurol Sci. 2010;31(1):35-40.
33. Bugalho P, Vale J. Brief cognitive assessment in the early stages of Parkinson disease. Cogn Behav Neurol. 2011;24(4): 169-173.
34. Emre M. What causes mental dysfunction in Parkinson's disease? Mov Disord. 2003;18 Suppl 6:S63-S71. (Pubitemid 37185198)
35. Vitale C, Santangelo G, Trojano L, Verde F, Rocco M, Grossi D, et al. Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease. Mov Disord. 2011;26(5):830-836.
36. Santangelo G, Vitale C, Trojano L,Verde F, Grossi D, Barone P. Cognitive dysfunctions and pathological gambling in patientswith Parkinson's disease.MovDisord. 2009;24(6):899-905.
37. Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, ZecchinelliAL, et al. Cognitive status of patientswith Parkinson's disease and pathological gambling. J Neurol. 2010; 257(2):247-252.
38. Pagonabarraga J, Garcia-Sanchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord. 2007;22(10):1430-1435. (Pubitemid 47280628)
39. Cronin-Golomb A. Parkinson's disease as a disconnection syndrome. Neuropsychol Rev 2010;20(2):191-208.
40. Bogdanova Y, Cronin-Golomb A. Neurocognitive correlates of apathy and anxiety in Parkinson's disease. Parkinsons Dis. 2012;2012:793076.
41. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, et al. Chronic dopaminergic stimulation in Parkinson's disease: From dyskinesias to impulse control disorders. Lancet Neurol. 2009;8(12):1140-1149.
42. VoonV, Sohr M, LangAE, Potenza MN, Siderowf AD,Whetteckey J, et al. Impulse control disorders in Parkinson disease: A multicenter case-control study. Ann Neurol. 2011; 69(6):986-996.
43. Spencer AH, Rickards H, Fasano A, Cavanna AE. The prevalence and clinical characteristics of punding in Parkinson's disease. Mov Disord. 2011;26(4):578-586.
44. Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ. Psychotic and compulsive symptoms in Parkinson's disease. Mov Disord. 2009;24(5):738-744.
45. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med. 1988;318(14):876-880. (Pubitemid 18090271)
46. Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, et al. Mechanisms underlying dopaminemediated reward bias in compulsive behaviors. Neuron. 2010;65(1):135-142.
47. FrankMJ, Seeberger LC, O'Reilly R C. By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science. 2004;306(5703):1940-1943. (Pubitemid 39627859)
48. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G,Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain. 2009;132(Pt 5):1376-1385.
49. Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. AnnNeurol. 2006;59(5):852-858. (Pubitemid 43673163)
50. Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, PotenzaMN, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord. 2010;25(11):1660-1669.
51. Cilia R, Cho SS, van Eimeren T, Marotta G, Siri C, Ko JH, et al. Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: A path modeling analysis. Mov Disord. 2011;26(2):225-233.
52. Cilia R, Siri C,MarottaG, Isaias IU,DeGaspariD, CanesiM, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol. 2008;65(12):1604-1611.
53. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: Results of imaging studies and treatment implications. Arch Neurol. 2007; 64(11):1575-1579. (Pubitemid 350106758)
54. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of themesolimbic reward system. NatNeurosci. 2005;8(2):147-148. (Pubitemid 40194043)
55. Cilia R,Ko JH, Cho SS, van Eimeren T,MarottaG, Pellecchia G, et al. Reduced dopamine transporter density in the ventral striatum of patientswith Parkinson's disease and pathological gambling. Neurobiol Dis. 2010;39(1):98-104.
56. Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, et al. Eating disorders with binge-eating behaviour are associated with the s allele of the 3'-UTR VNTR polymorphismof the dopamine transporter gene. J Psychiatry Neurosci. 2004;29(2):134-137. (Pubitemid 38570218)
57. Muramatsu T, Higuchi S. Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun. 1995;211(1):28-32.
58. Schmid B, Blomeyer D, Becker K, Treutlein J, Zimmermann US, Buchmann AF, et al. The interaction between the dopamine transporter gene and age at onset in relation to tobacco and alcohol use among 19-year-olds. Addict Biol. 2009;14(4):489-499.
59. Lind PA, Eriksson CJ,Wilhelmsen KC. Association between harmful alcohol consumption behavior and dopamine transporter (DAT1) gene polymorphisms in a male Finnish population. Psychiatr Genet. 2009;19(3):117-125.
60. Franklin TR, Lohoff FW,Wang Z, Sciortino N, Harper D, Li Y, et al. DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology. 2009;34(3):717-728.
61. Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord. 2011;18(4):397-399.
62. de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias. Brain. 2004;127(Pt 12): 2747-2754. (Pubitemid 39627382)
63. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: A narrative review. Neuropsychopharmacology. 2010;35(3): 591-604.
64. Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain. 2007;130(Pt 12): 3223-3236. (Pubitemid 350209066)
65. Aron AR, Poldrack RA. The cognitive neuroscience of response inhibition: Relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11):1285-1292. (Pubitemid 40798547)
66. Rogers R, Everitt B, Baldacchino A, Johnson A, Swainson R, London M, et al. Dissociable deficits in the decisionmaking cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20:322-339. (Pubitemid 29099763)
67. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7-15.
68. Clark L, Robbins TW, Ersche KD, Sahakian BJ. Reflection impulsivity in current and former substance users. Biol Psychiatry. 2006;60(5):515-522. (Pubitemid 44292153)
69. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, et al. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl). 1999;146(4):482-491. (Pubitemid 29513289)
70. Chamberlain SR, Fineberg NA,Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(2):335-338.
71. Masaki D, Yokoyama C, Kinoshita S, Tsuchida H, Nakatomi Y, Yoshimoto K, et al. Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats. Psychopharmacology (Berl). 2006;189(2):249-258. (Pubitemid 44691546)
72. Boulougouris V, Dalley JW, Robbins TW. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res. 2007;179(2):219-228. (Pubitemid 46497457)
73. Lapiz-Bluhm MD, Soto-Pina AE, Hensler JG, Morilak DA. Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl). 2009;202(1-3):329-341.
74. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. Cognitive inflexibility after prefrontal serotonin depletion. Science. 2004;304(5672):878-880. (Pubitemid 38620188)
75. Hatcher PD, Brown VJ, Tait DS, Bate S, Overend P, Hagan JJ, et al. 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology (Berl). 2005;181(2):253-259. (Pubitemid 41492195)
76. Tsaltas E, Kontis D, Chrysikakou S, Giannou H, Biba A, Pallidi S, et al. Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology. Biol Psychiatry. 2005;57(10):1176-1185. (Pubitemid 40615780)
77. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: Interactions with global 5-HT depletion. Psychopharmacology (Berl). 2004;176(3-4):376-385. (Pubitemid 40012745)
78. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315(5816):1267-1270. (Pubitemid 46364262)
79. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ. High impulsivity predicts the switch to compulsive cocaine-taking. Science. 2008;320(5881):1352- 1355. (Pubitemid 351929473)
80. Volkow ND, Fowler JS,WangGJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56 Suppl 1:3-8.
81. Adams CD. Variations in the sensitivity of instrumental responding to reinforcer devaluation. The Quarterly Journal of Experimental Psychology Section B1982 2012/06/18; 34(2):77-98.
82. Adams CD, Dickinson A. Instrumental responding following reinforcer devaluation. The Quarterly Journal of Experimental Psychology Section B1981 2012/06/18;33(2):109-21.
83. Colwill RM, Rescorla RA. Postconditioning devaluation of a reinforcer affects instrumental responding. Journal of Experimental Psychology: Animal Behavior Processes. 1985; 11(1):120-32.
84. Corbit LH, Ostlund SB, Balleine BW. Sensitivity to instrumental contingency degradation is mediated by the entorhinal cortex and its efferents via the dorsal hippocampus. J Neurosci. 2002;22(24):10976-84. (Pubitemid 36005174)
85. Dickinson A. Bidirectional Instrumental Conditioning. The Quarterly Journal of Experimental Psychology Section B. 1996 2012/06/18;49(4):289-306. (Pubitemid 126683276)
86. Hammond LJ. The effect of contingency upon the appetitive conditioning of free-operant behavior. J Exp Anal Behav. 1980;34(3):297-304.
87. Tricomi E, Balleine BW, O'Doherty JP. A specific role for posterior dorsolateral striatum in human habit learning. Eur J Neurosci. 2009;29(11):2225-2232.
88. Balleine BW, Dickinson A. Goal-directed instrumental action: Contingency and incentive learning and their cortical substrates. Neuropharmacology. 1998;37(4-5):407-419. (Pubitemid 28306930)
89. Balleine BW, Killcross AS, Dickinson A. The effect of lesions of the basolateral amygdala on instrumental conditioning. J Neurosci. 2003;23(2):666-675. (Pubitemid 36139565)
90. Coutureau E, Killcross S. Inactivation of the infralimbic prefrontal cortex reinstates goal-directed responding in overtrained rats. Behav Brain Res. 2003;146(1-2):167-174. (Pubitemid 37476143)
91. Yin HH, Knowlton BJ, Balleine BW. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci. 2004;19(1):181-189. (Pubitemid 38122084)
92. Yin HH, Knowlton BJ, Balleine BW. Blockade of NMDA receptors in the dorsomedial striatum prevents actionoutcome learning in instrumental conditioning. Eur J Neurosci. 2005;22(2):505-512. (Pubitemid 41097623)
93. Yin HH, Ostlund SB, Knowlton BJ, Balleine BW. The role of the dorsomedial striatum in instrumental conditioning. Eur J Neurosci. 2005;22(2):513-523. (Pubitemid 41097624)
94. Balleine BW, O'Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goaldirected and habitual action. Neuropsychopharmacology. 2010;35(1):48-69.
95. Yin HH, Mulcare SP, Hilario MR, Clouse E, Holloway T, Davis MI, et al. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci. 2009;12(3):333-341.
96. Yin HH, Knowlton BJ, Balleine BW. Inactivation of dorsolateral striatum enhances sensitivity to changes in the actionoutcome contingency in instrumental conditioning. Behav Brain Res. 2006;166(2):189-196. (Pubitemid 41785362)
97. Faure A, Haberland U, Conde F, El Massioui N. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J Neurosci. 2005;25(11):2771-2780. (Pubitemid 40389235)
98. Corbit LH, Balleine BW. The general and outcome-specific forms of Pavlovian-instrumental transfer are differentially mediated by the nucleus accumbens core and shell. J Neurosci. 2011;31(33):11786-11794.
99. Fecteau S, Knoch D, Fregni F, Sultani N, Boggio P, Pascual-Leone A. Diminishing risk-taking behavior by modulating activity in the prefrontal cortex: A direct current stimulation study. J Neurosci. 2007;27(46):12500-12505. (Pubitemid 350127819)
100. Knoch D, Gianotti LR, Pascual-Leone A, Treyer V, Regard M, HohmannM, et al. Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risk-taking behavior. J Neurosci. 2006;26(24):6469-6472. (Pubitemid 44318327)
101. Boggio PS, Campanha C, Valasek CA, Fecteau S, Pascual-Leone A, Fregni F. Modulation of decision-making in a gam bling task in older adults with transcranial direct current stimulation. Eur J Neurosci. 2010;31(3):593-597.
102. Boggio PS, Sultani N, Fecteau S, Merabet L, Mecca T, Pascual-Leone A, et al. Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: A double-blind, sham-controlled study. Drug Alcohol Depend. 2008;92(1-3):55-60. (Pubitemid 350218196)
103. Camprodon JA, Martinez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 2007;86(1):91-94. (Pubitemid 44708533)
104. Hilario MR, Costa RM. High on habits. Front Neurosci. 2008;2(2):208-217.
105. Tanaka SC, Balleine BW, O'Doherty JP. Calculating consequences: brain systems that encode the causal effects of actions. J Neurosci. 2008;28(26):6750-6755.